Net Cash Provided by (Used in) Operating Activities |
-405M |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
449M |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares, Issued |
22.8M |
shares |
|
Q1 2025 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
43.6M |
USD |
|
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
71M |
USD |
|
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
5.69M |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Gross |
2.4M |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
399K |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Federal Income Tax Expense (Benefit) |
-2.15M |
USD |
|
Q1 2025 |
Q1 2025 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
554M |
USD |
|
Q1 2025 |
Q1 2025 |
Current State and Local Tax Expense (Benefit) |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
2.4M |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred State and Local Income Tax Expense (Benefit) |
-208K |
USD |
|
Q1 2025 |
Q1 2025 |
Interest Expense |
3.97M |
USD |
|
Q1 2025 |
Q1 2025 |